Join Merz Therapeutics and Dr. Sublett for a keynote speech about IncobotulinumtoxinA:
Exciting News Around Treatment With IncobotulinumtoxinA
Immunogenicity and Treatment With IncobotulinumtoxinA
The objective of the symposium is to discuss immunogenicity and
incobotulinumtoxinA, including introduction of new study data.
Thursday, July 28, 2022
5:45 PM – 7:00 PM
in the Carondolet Room
Dr. J. Wesley Sublett* is a Louisville native, he joined Family Allergy and Asthma in 2011. Dr. Wes Sublett is a graduate of Transylvania University (BA), St. Louis University (MPH) and the University of Louisville School of Medicine. Board certified in both Pediatrics and Allergy & Immunology, Dr. Sublett completed his Internship and Residency in Pediatrics at the University of Louisville – Kosair Children’s Hospital. He then went on to complete his Fellowship in Allergy, Asthma and Immunology at the University of Cincinnati. He played a crucial role in getting a Kentucky House Bill passed that allows schools to purchase and store epinephrine auto-injectors and use them on children who fall into a life-threatening anaphylactic shock. Dr. Wes was present when Governor Beshear signed the bill into law in 2013.
*Dr. Sublett is a paid speaker of Merz Pharmaceuticals, LLC.
Copyright © 2022 Merz Pharmaceuticals, LLC. All rights reserved.
MERZ and the Merz logo are registered trademarks of Merz Pharma GmbH & Co. KGaA.
US-XET-2100231
